Advancements in GA pipeline brings first wave of therapies closer to patients
Recent advancements in late-stage therapies for geographic atrophy have raised hopes of ushering in its first wave of therapies.
By
GlobalData Healthcare
Latest articles
All Articles
Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022
The majority of the top 20 global biopharmaceutical companies continued their growth and experienced a favorable Q1 2022, retaining…
By
AAN 2022 highlights: complement inhibitors and pipeline assessment in neurology
Data were presented for several complement-targeting therapeutics at the American Academy of Neurology (AAN) 2022 Annual Meeting.
By
Biologic sales forecast to pass innovative small molecule sales in next five years
GlobalData has forecast biologic sales to significantly overtake sales of small molecules by $120bn by 2027.
By
Leverage existing Covid-19 networks to tackle paediatric hepatitis outbreak
The tools established to combat Covid-19 can be proactively leveraged before the hepatitis outbreak becomes any more serious.
By
Factors to consider for wider market penetration of Outlook Therapeutics’ ONS-5010
On March 31, 2022, Outlook Therapeutics submitted a Biologics License Application (BLA) to the FDA for ONS-5010 (bevacizumab-vikg) for…
By
VEGF inhibitor approvals drive competition in the DME global market
Recently, the diabetic macular edema (DME) space witnessed new approvals; the European Commission (EC) announced the approval of Novartis’s…
ByRussian pharma pipeline dominated by private entities, but no clear source of capital
In the wake of Russia’s invasion of Ukraine, there have been significant financial sanctions on the country, crippling the…
By
Bear markets: a vehicle for CMOs to onshore operations
Typically, securities prices fall 20% or more from recent highs amid widespread pessimism and negative investor sentiment.
By